ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

Plan posted for “public comment” on Dialogue’s Web site; who will respond, Dialogue or NCI? Cost estimate of network significantly reduced.

December 12, 2003

In Brief: No Intention Of Retiring, DeVita Says; Bresnick To Head Eppley; Balch Acting Director at Alabama

October 22, 1982

European regulators plan more rigorous rules for accelerated approval in cancer.

November 11, 2005

NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies

October 25, 2013

NIH Plans Consensus Conference On Ovarian Cancer April 5-7

January 28, 1994

Dipersio Is Chief Of Oncology At Washington University.

July 14, 2000